Acrivon Therapeutics annual operating expenses
2021
2022
2023
2024
2025
Acrivon Therapeutics Operating Expenses Growth & History (ACRV)
Acrivon Therapeutics's operating expenses was $84.1M for fiscal 2025.
View full Acrivon Therapeutics company overviewAcrivon Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $84.1M | −$5.1M | −5.70% |
| 2024 | 2024-12-31 | $89.2M | $22.1M | +32.93% |
| 2023 | 2023-12-31 | $67.1M | $34.4M | +105.48% |
| 2022 | 2022-12-31 | $32.7M | $16.5M | +101.79% |
| 2021 | 2021-12-31 | $16.2M | — | — |
Acrivon Therapeutics quarterly operating expenses
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.7M | −$4.0M | −17.58% |
| Q1 2026 | 2026-03-31 | $19.9M | −$1.8M | −8.12% |
| Q4 2025 | 2025-12-31 | $20.1M | −$4.8M | −19.39% |
| Q3 2025 | 2025-09-30 | $19.7M | −$5.5M | −21.69% |
| Q2 2025 | 2025-06-30 | $22.6M | $1.2M | +5.65% |
| Q1 2025 | 2025-03-31 | $21.7M | $4.0M | +22.61% |
| Q4 2024 | 2024-12-31 | $25.0M | $3.9M | +18.53% |
| Q3 2024 | 2024-09-30 | $25.1M | $9.0M | +55.79% |
| Q2 2024 | 2024-06-30 | $21.4M | $5.9M | +38.13% |
| Q1 2024 | 2024-03-31 | $17.7M | $3.3M | +22.75% |
| Q4 2023 | 2023-12-31 | $21.1M | $11.1M | +111.69% |
| Q3 2023 | 2023-09-30 | $16.1M | $6.6M | +68.53% |
| Q2 2023 | 2023-06-30 | $15.5M | $9.6M | +161.94% |
| Q1 2023 | 2023-03-31 | $14.4M | $7.2M | +99.57% |
| Q4 2022 | 2022-12-31 | $9.9M | — | — |
| Q3 2022 | 2022-09-30 | $9.6M | $6.9M | +258.48% |
| Q2 2022 | 2022-06-30 | $5.9M | — | — |
| Q1 2022 | 2022-03-31 | $7.2M | — | — |
| Q3 2021 | 2021-09-30 | $2.7M | — | — |
Acrivon Therapeutics operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Acrivon Therapeutics's operating expenses increased from $16.2M to $84.1M, a change of $67.9M. The latest reported quarter, Q2 2026, shows $18.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acrivon Therapeutics source filings ↗